FDA MedWatch

Two previously uncharacterized safety concerns associated with the use of colchicine.

Product recalled because samples were found to contain an undeclared drug ingredient.

Products are unapproved drugs and associated with serious risks of liver injury, stroke.

Nationwide recall due to potential risk of fire and burns for patient and caregiver

FDA analysis has found carcinogens and toxic chemicals such as diethylene glycol, an ingredient used in antifreeze.

Nationwide recall due to potential bacterial contamination, placing children with weakened immune systems at risk of harm.

Recall due to presence of elevated endotoxin levels in some vials.

Products recalled due to an undeclared drug ingredient which may present a significant health risk for patients with history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Posted 07/17/2009

FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) that suggests an increased number of cardiovascular and cerebrovascular adverse events.

Products recalled because samples were found to contain undeclared drug ingredients.